Stratrix
On the Record · Illumina

Illumina acquisitions, on the record

The businesses Illumina bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.

Deals its annual reports describe

BusinessDealWhenValue
GRAIL, LLC (f/k/a GRAIL, Inc.)
Word for word“On December 17, 2023, we announced that we will divest GRAIL.” 10-K for 2023
agreed divestitureOn December 17, 2023, we announced that we will divest GRAIL.—
GRAIL
Word for word“On August 18, 2021, we acquired GRAIL, a healthcare company focused on early detection of multiple cancers.” 10-K for 2023
acquisitionOn August 18, 2021, we acquired GRAIL, a healthcare company focused on early detection of multiple cancers.—
an acquisition (business not named in the quote)
Word for word“We invested $195 million in capital expenditures, primarily associated with our investment in facilities, paid $29 million, net of cash acquired, for an acquisition, and used $6 million for net purchases of strategic investments.” 10-K for 2023
acquisition—$29 million, net of cash acquired
Fluent BioSciences
Word for word“As a result of the Fluent BioSciences acquisition in Q3 2024, we recorded a developed technology asset of $ 42 million, with a useful life of 7 years, and a customer relationship asset of $ 2 million, with a useful life of 11 years.” 10-K for 2024
acquisitionQ3 2024—
GRAIL
Word for word“On June 24, 2024, we completed the separation of GRAIL into a separate, independent publicly traded company.” 10-K for 2025
divestitureJune 24, 2024—
As filedReported in the company's financial data (XBRL), each linked to its filing
Fiscal year endedCash paid for acquisitions (net of cash acquired)Goodwill from acquisitions
2017-01-01$18 million$23 million
2017-12-31$0—
2018-12-30$100 million$60 million
2019-12-29$0$73 million
2021-01-03$98 million—
2022-01-02$2.44 billion$6.2 billion
2023-01-01$265 million$45 million
2023-12-31$30 million$18 million
2024-12-29$81 million$34 million
2025-12-28$10 million—

Deal filings since 2016

Read from Illumina’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-12. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.